Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr John Anderson

Newcastle AuthorsTitleYearFull text
Dr Karen Barker
Philip Berry
Professor Gareth Veal
Dr John Anderson
In vivo Modelling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis2019
Professor Colin Rees
Dr John Anderson
Professor Matt Rutter
Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative2017
Dr Christine Challen
Dr John Anderson
Emerita Professor Zofia Chrzanowska-Lightowlers
Emeritus Professor Robert Lightowlers
Professor John Lunec
Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA2012
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr John Anderson
Lynne Overman
Dr Katrina Wood
Professor Stephen Proctor
Dr Stephen Crosier
et al.		Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics2009
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Brian Angus
Professor Stephen Proctor
et al.		A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22008
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
Dr John Anderson
CD31 density is a new risk factor for patients with B-cell chronic lymphocytic leukaemia2008
Dr Tryfonia Mainou-Fowler
Dr John Anderson
Professor Stephen Proctor
CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia2008
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Dr Christine Challen
Professor John Lunec
The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer2008
Dr Xiaomei Lu
Dr Simon Baudouin
Professor James Gillespie
Dr John Anderson
Professor Anne Dickinson
A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133+ and CD34+ cells2007
Dr Xiaomei Lu
Dr Simon Baudouin
Professor James Gillespie
Dr John Anderson
Professor Anne Dickinson
A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133+ and CD34+ cells2007
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Stephen Crosier
Dr Brian Angus
et al.		A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22007
Dr Rachel Crossland
Dr Christine Challen
Dr Bridget Wilkins
Dr Stephen Crosier
Dr John Anderson
Definitive identification of the Val617Phe mutation in myeloproliferative disorders using Real Time PCR utilising Roche Lightcycler/hybriprobe technology2007
12345